In vitro/in vivo toxicity evaluation and quantification of iron oxide nanoparticles

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 24417-24450

  Patil, Ujwal S ^a   Adireddy, Shiva ^b   Jaiswal, Ashvin ^c   Mandava, Sree ^d   Lee, Benjamin R ^d   Chrisey, Douglas B ^b  

^a UNIVERSITY OF NEW ORLEANS   (United States)

^b Tulane University   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Iron oxide nanoparticles; Physicochemical properties; Quantification; Toxicity

Indexed keywords

(3 AMINOPROPYL)TRIMETHOXYSILANE; CHITOSAN NANOPARTICLE; COPOLYMER; DEXTRAN; MACROGOL; MESO 2,3 DIMERAPTOSUCCINIC ACID; PARATHYROID HORMONE; POLY(ETHYLENE GLYCOL) POLY(ASPARTATE) BLOCK COPOLYMER; POLYLYSINE; PROTEIN; PROTEIN CORONA; REACTIVE OXYGEN METABOLITE; SILANE DERIVATIVE; SUCCINIC ACID DERIVATIVE; SUPERPARAMAGNETIC IRON OXIDE; TETRAETHOXYSILANE; TRIETHOXYVINYLSILANE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ABSORPTION; CHEMICAL COMPOSITION; CLEARANCE; CORRELATION ANALYSIS; CYTOTOXICITY; DISTRIBUTION PARAMETERS; EXCRETION; EXPOSURE; GENOTOXICITY; HUMAN; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INVASIVE PROCEDURE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METABOLISM; MORPHOLOGICAL TRAIT; MTS ASSAY; MTT ASSAY; NANOMEDICINE; NON INVASIVE PROCEDURE; NONHUMAN; REVIEW; SPECTROPHOTOMETRY; SURFACE PROPERTY; TOXICITY ASSAY; XTT ASSAY; ANIMAL; CELL DEATH; DRUG EFFECTS;

ANIMALS; CELL DEATH; FERRIC COMPOUNDS; HUMANS; METAL NANOPARTICLES;

EID: 84945199333     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161024417     Document Type: Review

References (180)

1. Gu, L.Z.; Hong, Q.; Xiang, C.J. The application of nanotechnology for mechanical manufacturing. Key Eng. Mater. 2010, 447-448, 86-90
2. Cavalcanti, A.; Freitas, R.A., Jr. Nanorobotics control design: A collective behavior approach for medicine. IEEE Trans. Nanobiosci. 2005, 4, 133-140
3. Hobson, D.W. Commercialization of nanotechnology. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1, 189-202
4. Venkatraman, S. Has nanomedicine lived up to its promise? Nanotechnology 2014, 25, 372501
5. Xu, C.; Sun, S. New forms of superparamagnetic nanoparticles for biomedical applications. Adv. Drug Deliv. Rev. 2013, 65, 732-743
6. Estelrich, J.; Sanchez-Martin, M.J.; Busquets, M.A. Nanoparticles in magnetic resonance imaging: From simple to dual contrast agents. Int. J. Nanomed. 2015, 10, 1727-1741
7. Estelrich, J.; Escribano, E.; Queralt, J.; Busquets, M.A. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int. J. Mol. Sci. 2015, 16, 8070-8101
8. Sawdon, A.; Weydemeyer, E.; Peng, C.A. Antitumor therapy using nanomaterial-mediated thermolysis. J. Biomed. Nanotechnol. 2014, 10, 1894-1917
9. Villanueva, A.; Canete, M.; Roca, A.G.; Calero, M.; Veintemillas-Verdaguer, S.; Serna, C.J.; del Puerto Morales, M.; Miranda, R. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 2009, 20, 115103
10. Malhotra, M.; Prakash, S. Targeted drug delivery across blood-brain-barrier using cell penetrating peptides tagged nanoparticles. Curr. Nanosci. 2011, 7, 81-93
11. Ansciaux, E.; Burtea, C.; Laurent, S.; Crombez, D.; Nonclercq, D.; Vander Elst, L.; Muller, R.N. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: Toward earlier diagnosis of Alzheimer’s disease by molecular imaging. Contrast Media Mol. Imaging 2015, 10, 211-224
12. Koh, I.; Josephson, L. Magnetic nanoparticle sensors. Sensors 2009, 9, 8130-8145
13. Patil, U.S.; Qu, H.; Caruntu, D.; O’Connor, C.J.; Sharma, A.; Cai, Y.; Tarr, M.A. Labeling primary amine groups in peptides and proteins with N-hydroxysuccinimidyl ester modified Fe3O4@SiO2 nanoparticles containing cleavable disulfide-bond linkers. Bioconjug. Chem. 2013, 24, 1562-1569
14. Patil, U.S.; Osorno, L.; Ellender, A.; Grimm, C.; Tarr, M.A. Cleavable ester-linked magnetic nanoparticles for labeling of solvent-exposed primary amine groups of peptides/proteins. Anal. Biochem. 2015, 484, 18-20
15. Basu, S.; Chatterjee, S.; Bandyopadhyay, A.; Sarkar, K. Potential application of superparamagnetic nanoparticles for extraction of bacterial genomic DNA from contaminated food and environmental samples. J. Sci. Food Agric. 2013, 93, 788-793
16. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627
17. Singh, S.; Nalwa, H.S. Nanotechnology and health safety-Toxicity and risk assessments of nanostructured materials on human health. J. Nanosci. Nanotechnol. 2007, 7, 3048-3070
18. Nanotechnology Characterization Laboratory. Available online: http://ncl.cancer.gov/(accesses on 5 July 2015)
19. Juillerat-Jeanneret, L.; Dusinska, M.; Fjellsbo, L.M.; Collins, A.R.; Handy, R.D.; Riediker, M. Biological impact assessment of nanomaterial used in nanomedicine. introduction to the NanoTEST project. Nanotoxicology 2015, 9 (Suppl. 1), 5-12
20. Armstrong, J.S.; Steinauer, K.K.; Hornung, B.; Irish, J.M.; Lecane, P.; Birrell, G.W.; Peehl, D.M.; Knox, S.J. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ. 2002, 9, 252-263
21. Ayala, A.; Muoz, M.F.; Arguelles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med. Cell. Longev. 2014, 2014, 31
22. Srinivasan, A.; Lehmler, H.J.; Robertson, L.W.; Ludewig, G. Production of DNA strand breaks in vitro and reactive oxygen species in vitro and in HL-60 cells by PCB metabolites. Toxicol. Sci. 2001, 60, 92-102
23. Ziech, D.; Franco, R.; Pappa, A.; Panayiotidis, M.I. Reactive oxygen species (ROS)—Induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 2011, 711, 167-173
24. Sharma, P.; Jha, A.B.; Dubey, R.S.; Pessarakli, M. Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. J. Bot. 2012, 2012, 26
25. Sugamura, K.; Keaney, J.F., Jr. Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med. 2011, 51, 978-992
26. Liou, G.Y.; Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 2010, 44, 479-496
27. Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 2014, 20, 1126-1167
28. Giacco, F.; Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 2010, 107, 1058-1070
29. Zuo, L.; Motherwell, M.S. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson’s disease. Gene 2013, 532, 18-23
30. Gelderman, K.A.; Hultqvist, M.; Olsson, L.M.; Bauer, K.; Pizzolla, A.; Olofsson, P.; Holmdahl, R. Rheumatoid arthritis: The role of reactive oxygen species in disease development and therapeutic strategies. Antioxid. Redox Signal. 2007, 9, 1541-1567
31. Wu, H.; Yin, J.J.; Wamer, W.G.; Zeng, M.; Lo, Y.M. Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J. Food Drug Anal. 2014, 22, 86-94
32. Goldstein, S.; Meyerstein, D.; Czapski, G. The Fenton reagents. Free Radic. Biol. Med. 1993, 15, 435-445
33. Voinov, M.A.; Pagán, J.O.S.; Morrison, E.; Smirnova, T.I.; Smirnov, A.I. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J. Am. Chem. Soc. 2011, 133, 35-41
34. Valdiglesias, V.; Kilic, G.; Costa, C.; Fernandez-Bertolez, N.; Pasaro, E.; Teixeira, J.P.; Laffon, B. Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity. Environ. Mol. Mutagen. 2015, 56, 125-148
35. Ying, E.; Hwang, H.-M. In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci. Total Environ. 2010, 408, 4475-4481
36. Yang, L.; Kuang, H.; Zhang, W.; Aguilar, Z.P.; Xiong, Y.; Lai, W.; Xu, H.; Wei, H. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale 2015, 7, 625-636
37. Karlsson, H.L.; Gustafsson, J.; Cronholm, P.; Möller, L. Size-dependent toxicity of metal oxide particles—A comparison between nano- and micrometer size. Toxicol. Lett. 2009, 188, 112-118
38. Lee, J.H.; Ju, J.E.; Kim, B.I.; Pak, P.J.; Choi, E.K.; Lee, H.S.; Chung, N. Rod-shaped iron oxide nanoparticles are more toxic than sphere-shaped nanoparticles to murine macrophage cells. Environ. Toxicol. Chem. 2014, 33, 2759-2766
39. Magdolenova, Z.; Drlickova, M.; Henjum, K.; Runden-Pran, E.; Tulinska, J.; Bilanicova, D.; Pojana, G.; Kazimirova, A.; Barancokova, M.; Kuricova, M. et al. Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles. Nanotoxicology 2015, 9 (Suppl. 1), 44-56
40. Malvindi, M.A.; de Matteis, V.; Galeone, A.; Brunetti, V.; Anyfantis, G.C.; Athanassiou, A.; Cingolani, R.; Pompa, P.P. Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS ONE 2014, 9, e85835
41. Levy, M.; Lagarde, F.; Maraloiu, V.A.; Blanchin, M.G.; Gendron, F.; Wilhelm, C.; Gazeau, F. Degradability of superparamagnetic nanoparticles in a model of intracellular environment: Follow-up of magnetic, structural and chemical properties. Nanotechnology 2010, 21, 395103
42. Xue, X.; Hanna, K.; Deng, N. Fenton-like oxidation of Rhodamine B in the presence of two types of iron (II, III) oxide. J. Hazard. Mater. 2009, 166, 407-414
43. Gorski, C.A.; Nurmi, J.T.; Tratnyek, P.G.; Hofstetter, T.B.; Scherer, M.M. Redox Behavior of Magnetite: Implications for contaminant reduction. Environ. Sci. Technol. 2010, 44, 55-60
44. Chen, Z.; Yin, J.-J.; Zhou, Y.-T.; Zhang, Y.; Song, L.; Song, M.; Hu, S.; Gu, N. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 2012, 6, 4001-4012
45. Hermanek, M.; Zboril, R.; Medrik, I.; Pechousek, J.; Gregor, C. Catalytic efficiency of iron(III) oxides in decomposition of hydrogen peroxide: Competition between the surface area and crystallinity of nanoparticles. J. Am. Chem. Soc. 2007, 129, 10929-10936
46. Park, E.J.; Umh, H.N.; Choi, D.H.; Cho, M.H.; Choi, W.; Kim, S.W.; Kim, Y.; Kim, J.H. Magnetite-and maghemite-induced different toxicity in murine alveolar macrophage cells. Arch. Toxicol. 2014, 88, 1607-1618
47. Cromer Berman, S.M.; Kshitiz M; Wang, C.J.; Orukari, I.; Levchenko, A.; Bulte, J.W.M.; Walczak, P. Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn. Reson. Med. 2013, 69, 255-262
48. Wu, X.; Tan, Y.; Mao, H.; Zhang, M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int. J. Nanomed. 2010, 5, 385-399
49. Buyukhatipoglu, K.; Clyne, A.M. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J. Biomed. Mater. Res. Part A 2011, 96, 186-195
50. Zhang, W.; Kalive, M.; Capco, D.G.; Chen, Y. Adsorption of hematite nanoparticles onto Caco-2 cells and the cellular impairments: Effect of particle size. Nanotechnology 2010, 21, 355103
51. Kalive, M.; Zhang, W.; Chen, Y.; Capco, D. Human intestinal epithelial cells exhibit a cellular response indicating a potential toxicity upon exposure to hematite nanoparticles. Cell Biol. Toxicol. 2012, 28, 343-368
52. Astanina, K.; Simon, Y.; Cavelius, C.; Petry, S.; Kraegeloh, A.; Kiemer, A.K. Superparamagnetic iron oxide nanoparticles impair endothelial integrity and inhibit nitric oxide production. Acta Biomater. 2014, 10, 4896-4911
53. Mesarosova, M.; Kozics, K.; Babelova, A.; Regendova, E.; Pastorek, M.; Vnukova, D.; Buliakova, B.; Razga, F.; Gabelova, A. The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles. Toxicol. Lett. 2014, 226, 303-313
54. Kedziorek, D.A.; Muja, N.; Walczak, P.; Ruiz-Cabello, J.; Gilad, A.A.; Jie, C.C.; Bulte, J.W. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn. Reson. Med. 2010, 63, 1031-1043
55. Alarifi, S.; Ali, D.; Alkahtani, S.; Alhader, M.S. Iron oxide nanoparticles induce oxidative stress, DNA damage, and caspase activation in the human breast cancer cell line. Biol. Trace Elem. Res. 2014, 159, 416-424
56. Ahamed, M.; Alhadlaq, H.A.; Alam, J.; Khan, M.A.; Ali, D.; Alarafi, S. Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr. Pharma. Des. 2013, 19, 6681-6690
57. Couto, D.; Freitas, M.; Porto, G.; Lopez-Quintela, M.A.; Rivas, J.; Freitas, P.; Carvalho, F.; Fernandes, E. Polyacrylic acid-coated and non-coated iron oxide nanoparticles induce cytokine activation in human blood cells through TAK1, p38 MAPK and JNK pro-inflammatory pathways. Arch. Toxicol. 2015, 89, 1759-1769
58. Liu, Y.; Wang, J. Effects of DMSA-coated Fe3O4 nanoparticles on the transcription of genes related to iron and osmosis homeostasis. Toxicol. Sci. 2013, 131, 521-536
59. Singh, S.P.; Rahman, M.F.; Murty, U.S.; Mahboob, M.; Grover, P. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol. Appl. Pharmacol. 2013, 266, 56-66
60. Faust, J.J.; Zhang, W.; Chen, Y.; Capco, D.G. α-Fe2O3 elicits diameter-dependent effects during exposure to an in vitro model of the human placenta. Cell Biol. Toxicol. 2014, 30, 31-53
61. Liu, Y.; Xia, Q.; Liu, Y.; Zhang, S.; Cheng, F.; Zhong, Z.; Wang, L.; Li, H.; Xiao, K. Genotoxicity assessment of magnetic iron oxide nanoparticles with different particle sizes and surface coatings. Nanotechnology 2014, 25, 425101
62. Yang, W.; Lee, J.; Hong, S.; Lee, J.; Lee, J.; Han, D.-W. Difference between toxicities of iron oxide magnetic nanoparticles with various surface-functional groups against human normal fibroblasts and fibrosarcoma cells. Materials 2013, 6, 4689-4706
63. Singh, N.; Jenkins, G.J.; Nelson, B.C.; Marquis, B.J.; Maffeis, T.G.; Brown, A.P.; Williams, P.M.; Wright, C.J.; Doak, S.H. The role of iron redox state in the genotoxicity of ultrafine superparamagnetic iron oxide nanoparticles. Biomaterials 2012, 33, 163-170
64. Mahmoudi, M.; Sheibani, S.; Milani, A.S.; Rezaee, F.; Gauberti, M.; Dinarvand, R.; Vali, H. Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomedicine 2015, 10, 215-226
65. Laurent, S.; Burtea, C.; Thirifays, C.; Rezaee, F.; Mahmoudi, M. Significance of cell “observer” and protein source in nanobiosciences. J. Colloid Interface Sci. 2013, 392, 431-445
66. Mahmoudi, M.; Abdelmonem, A.M.; Behzadi, S.; Clement, J.H.; Dutz, S.; Ejtehadi, M.R.; Hartmann, R.; Kantner, K.; Linne, U.; Maffre, P. et al. Temperature: The “ignored” factor at the NanoBio interface. ACS Nano 2013, 7, 6555-6562
67. Laurent, S.; Burtea, C.; Thirifays, C.; Hafeli, U.O.; Mahmoudi, M. Crucial ignored parameters on nanotoxicology: The importance of toxicity assay modifications and “cell vision”. PLoS ONE 2012, 7, e29997
68. Mbeh, D.A.; Mireles, L.K.; Stanicki, D.; Tabet, L.; Maghni, K.; Laurent, S.; Sacher, E.; Yahia, L. Human alveolar epithelial cell responses to core-shell superparamagnetic iron oxide nanoparticles (SPIONs). Langmuir 2015, 31, 3829-3839
69. Mahmoudi, M.; Shokrgozar, M.A.; Behzadi, S. Slight temperature changes affect protein affinity and cellular uptake/toxicity of nanoparticles. Nanoscale 2013, 5, 3240-3244.
70. Weissleder, R.; Stark, D.D.; Engelstad, B.L.; Bacon, B.R.; Compton, C.C.; White, D.L.; Jacobs, P.; Lewis, J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. Am. J. Roentgenol. 1989, 152, 167-173
71. Josephson, L.; Groman, E.V.; Menz, E.; Lewis, J.M.; Bengele, H. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Reson. Imaging 1990, 8, 637-646
72. Malvindi, M.A.; Greco, A.; Conversano, F.; Figuerola, A.; Corti, M.; Bonora, M.; Lascialfari, A.; Doumari, H.A.; Moscardini, M.; Cingolani, R. et al. Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv. Funct. Mater. 2011, 21, 2548-2555
73. Wang, Y.-X.J. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant. Imaging Med. Surg. 2011, 1, 35-40
74. Castaneda, R.T.; Khurana, A.; Khan, R.; Daldrup-Link, H.E. Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J. Vis. Exp. 2011, doi:10.3791/3482
75. Kolhatkar, A.G.; Jamison, A.C.; Litvinov, D.; Willson, R.C.; Lee, T.R. Tuning the magnetic properties of nanoparticles. Int. J. Mol. Sci. 2013, 14, 15977-16009
76. Chiriaco, F.; Soloperto, G.; Greco, A.; Conversano, F.; Ragusa, A.; Menichetti, L.; Casciaro, S. Magnetically-coated silica nanospheres for dual-mode imaging at low ultrasound frequency. World J. Radiol. 2013, 5, 411-420
77. Urbanova, V.; Magro, M.; Gedanken, A.; Baratella, D.; Vianello, F.; Zboril, R. Nanocrystalline iron oxides, composites, and related materials as a platform for electrochemical, magnetic, and chemical biosensors. Chem. Mater. 2014, 26, 6653-6673
78. Doak, S.H.; Griffiths, S.M.; Manshian, B.; Singh, N.; Williams, P.M.; Brown, A.P.; Jenkins, G.J. Confounding experimental considerations in nanogenotoxicology. Mutagenesis 2009, 24, 285-293
79. Mahmoudi, M.; Simchi, A.; Imani, M.; Shokrgozar, M.A.; Milani, A.S.; Hafeli, U.O.; Stroeve, P. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Coll. Surf. B Biointerfaces 2010, 75, 300-309
80. Gonzales, M.; Mitsumori, L.M.; Kushleika, J.V.; Rosenfeld, M.E.; Krishnan, K.M. Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127. Contrast Media Mol. Imaging 2010, 5, 286-293
81. Pfaller, T.; Colognato, R.; Nelissen, I.; Favilli, F.; Casals, E.; Ooms, D.; Leppens, H.; Ponti, J.; Stritzinger, R.; Puntes, V. et al. The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events. Nanotoxicology 2010, 4, 52-72
82. Cai, H.; An, X.; Cui, J.; Li, J.; Wen, S.; Li, K.; Shen, M.; Zheng, L.; Zhang, G.; Shi, X. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl. Mater. Interfaces 2013, 5, 1722-1731
83. Yu, M.; Huang, S.; Yu, K.J.; Clyne, A.M. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 2012, 13, 5554-5570
84. Shukla, S.; Jadaun, A.; Arora, V.; Sinha, R.K.; Biyani, N.; Jain, V.K. In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles. Toxicol. Rep. 2015, 2, 27-39
85. Ebrahiminezhad, A.; Rasoul-Amini, S.; Kouhpayeh, A.; Davaran, S.; Barar, J.; Ghasemi, Y. Impacts of amine functionalized iron oxide nanoparticles on HepG2 cell line. Curr. Nanosci. 2015, 11, 113-119
86. Chang, Y.K.; Liu, Y.P.; Ho, J.H.; Hsu, S.C.; Lee, O.K. Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells. J. Orthop. Res. 2012, 30, 1499-1506
87. Shen, M.; Cai, H.; Wang, X.; Cao, X.; Li, K.; Wang, S.H.; Guo, R.; Zheng, L.; Zhang, G.; Shi, X. Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology 2012, 23, 105601
88. Sharma, G.; Kodali, V.; Gaffrey, M.; Wang, W.; Minard, K.R.; Karin, N.J.; Teeguarden, J.G.; Thrall, B.D. Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro. Nanotoxicology 2014, 8, 663-675
89. Hong, S.C.; Lee, J.H.; Lee, J.; Kim, H.Y.; Park, J.Y.; Cho, J.; Lee, J.; Han, D.W. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int. J. Nanomed. 2011, 6, 3219-3231
90. Sun, Z.; Yathindranath, V.; Worden, M.; Thliveris, J.A.; Chu, S.; Parkinson, F.E.; Hegmann, T.; Miller, D.W. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models. Int. J. Nanomed. 2013, 8, 961-970
91. Mahmoudi, M.; Hofmann, H.; Rothen-Rutishauser, B.; Petri-Fink, A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 2012, 112, 2323-2338
92. Naqvi, S.; Samim, M.; Abdin, M.; Ahmed, F.J.; Maitra, A.; Prashant, C.; Dinda, A.K. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int. J. Nanomed. 2010, 5, 983-989
93. Mendes, R.G.; Koch, B.; Bachmatiuk, A.; El-Gendy, A.A.; Krupskaya, Y.; Springer, A.; Klingeler, R.; Schmidt, O.; Büchner, B.; Sanchez, S. et al. Synthesis and toxicity characterization of carbon coated iron oxide nanoparticles with highly defined size distributions. Biochim. Biophys. Acta 2014, 1840, 160-169
94. Dwivedi, S.; Siddiqui, M.A.; Farshori, N.N.; Ahamed, M.; Musarrat, J.; Al-Khedhairy, A.A. Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells. Coll. Surf. B Biointerfaces 2014, 122, 209-215
95. Taupitz, M.; Wagner, S.; Schnorr, J.; Kravec, I.; Pilgrimm, H.; Bergmann-Fritsch, H.; Hamm, B. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Investig. Radiol. 2004, 39, 394-405
96. Hoskins, C.; Cuschieri, A.; Wang, L. The cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J. Nanobiotechnol. 2012, 10, 15
97. Zhang, Y.; Yang, M.; Ozkan, M.; Ozkan, C.S. Magnetic force microscopy of iron oxide nanoparticles and their cellular uptake. Biotechnol. Prog. 2009, 25, 923-928
98. Love, S.A.; Maurer-Jones, M.A.; Thompson, J.W.; Lin, Y.S.; Haynes, C.L. Assessing nanoparticle toxicity. Annu. Rev. Anal. Chem. 2012, 5, 181-205
99. Baker, B.M.; Chen, C.S. Deconstructing the third dimension: How 3D culture microenvironments alter cellular cues. J. Cell Sci. 2012, 125, 3015-3024
100. Da Rocha, E.L.; Porto, L.M.; Rambo, C.R. Nanotechnology meets 3D in vitro models: Tissue engineered tumors and cancer therapies. Mater. Sci. Eng. C 2014, 34, 270-279
101. Lee, J.; Lilly, G.D.; Doty, R.C.; Podsiadlo, P.; Kotov, N.A. In vitro toxicity testing of nanoparticles in 3D cell culture. Small 2009, 5, 1213-1221
102. Luo, Y.; Wang, C.; Hossain, M.; Qiao, Y.; Ma, L.; An, J.; Su, M. Three-dimensional microtissue assay for high-throughput cytotoxicity of nanoparticles. Anal. Chem. 2012, 84, 6731-6738
103. Nancy A. Monteiro-Riviere, C.L.T. Nanotoxicology: Progress toward Nanomedicine, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2014
104. Lankoff, A.; Arabski, M.; Wegierek-Ciuk, A.; Kruszewski, M.; Lisowska, H.; Banasik-Nowak, A.; Rozga-Wijas, K.; Wojewodzka, M.; Slomkowski, S. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology 2013, 7, 235-250
105. Guo, X.; Mao, F.; Wang, W.; Yang, Y.; Bai, Z. Sulfhydryl-modified Fe3O4@SiO2 core/shell nanocomposite: Synthesis and toxicity assessment in vitro. ACS Appl. Mater. Interfaces 2015, 7, 14983-14991
106. Iqbal, M.Z.; Ma, X.; Chen, T.; Zhang, L.E.; Ren, W.; Xiang, L.; Wu, A. Silica-coated super-paramagnetic iron oxide nanoparticles (SPIONPs): A new type contrast agent of T1 magnetic resonance imaging (MRI). J. Mater. Chem. B 2015, 3, 5172-5181
107. Yuan, G.; Yuan, Y.; Xu, K.; Luo, Q. Biocompatible PEGylated Fe3O4 nanoparticles as photothermal agents for near-infrared light modulated cancer therapy. Int. J. Mol. Sci. 2014, 15, 18776-18788
108. Dai, L.; Liu, Y.; Wang, Z.; Guo, F.; Shi, D.; Zhang, B. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement. Mater. Sci. Eng. C 2014, 41, 161-167
109. Al Faraj, A. Preferential magnetic nanoparticle uptake by bone marrow derived macrophages sub-populations: Effect of surface coating on polarization, toxicity, and in vivo MRI detection. J. Nanopart. Res. 2013, 15, 1-13
110. Park, Y.C.; Smith, J.B.; Pham, T.; Whitaker, R.D.; Sucato, C.A.; Hamilton, J.A.; Bartolak-Suki, E.; Wong, J.Y. Effect of PEG molecular weight on stability, T2 contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs). Coll. Surf. B Biointerfaces 2014, 119, 106-114
111. Dan, M.; Scott, D.F.; Hardy, P.A.; Wydra, R.J.; Hilt, J.Z.; Yokel, R.A.; Bae, Y. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles. Pharm. Res. 2013, 30, 552-561
112. Lindemann, A.; Ludtke-Buzug, K.; Fraderich, B.M.; Grafe, K.; Pries, R.; Wollenberg, B. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Int. J. Nanomed. 2014, 9, 5025-5040
113. Zavisova, V.; Koneracka, M.; Kovac, J.; Kubovcikova, M.; Antal, I.; Kopcansky, P.; Bednarikova, M.; Muckova, M. The cytotoxicity of iron oxide nanoparticles with different modifications evaluated in vitro. J. Magn. Magn. Mater. 2015, 380, 85-89
114. Easo, S.L.; Mohanan, P.V. Dextran stabilized iron oxide nanoparticles: Synthesis, characterization and in vitro studies. Carbohydr. Polym. 2013, 92, 726-732
115. Barrow, M.; Taylor, A.; Nieves, D.J.; Bogart, L.K.; Mandal, P.; Collins, C.M.; Moore, L.R.; Chalmers, J.J.; Levy, R.; Williams, S.R. et al. Tailoring the surface charge of dextran-based polymer coated SPIONs for modulated stem cell uptake and MRI contrast. Biomater. Sci. 2015, 3, 608-616
116. Novotna, B.; Jendelova, P.; Kapcalova, M.; Rossner, P., Jr; Turnovcova, K.; Bagryantseva, Y.; Babic, M.; Horak, D.; Sykova, E. Oxidative damage to biological macromolecules in human bone marrow mesenchymal stromal cells labeled with various types of iron oxide nanoparticles. Toxicol. Lett. 2012, 210, 53-63
117. Neubert, J.; Wagner, S.; Kiwit, J.; Brauer, A.U.; Glumm, J. New findings about iron oxide nanoparticles and their different effects on murine primary brain cells. Int. J. Nanomed. 2015, 10, 2033-2049
118. Xiao, Y.; Lin, Z.T.; Chen, Y.; Wang, H.; Deng, Y.L.; Le, D.E.; Bin, J.; Li, M.; Liao, Y.; Liu, Y. et al. High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging. Int. J. Nanomed. 2015, 10, 1155-1172
119. Shi, S.F.; Jia, J.F.; Guo, X.K.; Zhao, Y.P.; Chen, D.S.; Guo, Y.Y.; Cheng, T.; Zhang, X.L. Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells. Int. J. Nanomed. 2012, 7, 5593-5602
120. Unsoy, G.; Yalcin, S.; Khodadust, R.; Gunduz, G.; Gunduz, U. Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J. Nanopart. Res. 2012, 14, 1-13
121. Grudzinski, I.P.; Bystrzejewski, M.; Cywinska, M.A.; Kosmider, A.; Poplawska, M.; Cieszanowski, A.; Ostrowska, A. Cytotoxicity evaluation of carbon-encapsulated iron nanoparticles in melanoma cells and dermal fibroblasts. J. Nanopart. Res. 2013, 15, 1835
122. NDong, C.; Tate, J.A.; Kett, W.C.; Batra, J.; Demidenko, E.; Lewis, L.D.; Hoopes, P.J.; Gerngross, T.U.; Griswold, K.E. Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo. PLoS ONE 2015, 10, e0115636
123. Gu, L.; Fang, R.H.; Sailor, M.J.; Park, J.-H. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano 2012, 6, 4947-4954
124. Jain, T.K.; Reddy, M.K.; Morales, M.A.; Leslie-Pelecky, D.L.; Labhasetwar, V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol. Pharm. 2008, 5, 316-327
125. Ruiz, A.; Hernandez, Y.; Cabal, C.; Gonzalez, E.; Veintemillas-Verdaguer, S.; Martinez, E.; Morales, M.P. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. Nanoscale 2013, 5, 11400-11408
126. Di Bona, K.R.; Xu, Y.; Ramirez, P.A.; DeLaine, J.; Parker, C.; Bao, Y.; Rasco, J.F. Surface charge and dosage dependent potential developmental toxicity and biodistribution of iron oxide nanoparticles in pregnant CD-1 mice. Reprod. Toxicol. 2014, 50, 36-42
127. Bellusci, M.; La Barbera, A.; Padella, F.; Mancuso, M.; Pasquo, A.; Grollino, M.G.; Leter, G.; Nardi, E.; Cremisini, C.; Giardullo, P. et al. Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process. Int. J. Nanomed. 2014, 9, 1919-1929
128. Kim, J.S.; Yoon, T.J.; Yu, K.N.; Kim, B.G.; Park, S.J.; Kim, H.W.; Lee, K.H.; Park, S.B.; Lee, J.K.; Cho, M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89, 338-347
129. Ganong, W.F. Circumventricular organs: Definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 2000, 27, 422-427
130. Tang, Z.; Li, D.; Sun, H.; Guo, X.; Chen, Y.; Zhou, S. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density. Biomaterials 2014, 35, 8015-8027
131. Wang, J.; Chen, Y.; Chen, B.; Ding, J.; Xia, G.; Gao, C.; Cheng, J.; Jin, N.; Zhou, Y.; Li, X. et al. Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice. Int. J. Nanomed. 2010, 5, 861-866
132. Boehm, I. Magnetic resonance cell-tracking studies: Spectrophotometry-based method for the quantification of cellular iron content after loading with superparamagnetic iron oxide nanoparticles. Mol. Imaging 2011, 10, 270-277
133. Hellborg, R.; Skog, G. Accelerator mass spectrometry. Mass Spectrom. Rev. 2008, 27, 398-427
134. Malfatti, M.A.; Palko, H.A.; Kuhn, E.A.; Turteltaub, K.W. Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. Nano Lett. 2012, 12, 5532-5538
135. Carter, P. Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal. Biochem. 1971, 40, 450-458
136. Viollier, E.; Inglett, P.W.; Hunter, K.; Roychoudhury, A.N.; van Cappellen, P. The ferrozine method revisited: Fe(II)/Fe(III) determination in natural waters. Appl. Geochem. 2000, 15, 785-790
137. Im, J.; Lee, J.; Löffler, F.E. Interference of ferric ions with ferrous iron quantification using the ferrozine assay. J. Microbiol. Methods 2013, 95, 366-367
138. Anastácio, A.S.; Harris, B.; Yoo, H.-I.; Fabris, J.D.; Stucki, J.W. Limitations of the ferrozine method for quantitative assay of mineral systems for ferrous and total iron. Geochim. Cosmochim. Acta 2008, 72, 5001-5008
139. Wu, Y.J.; Muldoon, L.L.; Varallyay, C.; Markwardt, S.; Jones, R.E.; Neuwelt, E.A. In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging. Am. J. Physiol. Cell Physiol. 2007, 293, C1698-C1708
140. Wang, Z.; Cuschieri, A. Tumour cell labelling by magnetic nanoparticles with determination of intracellular iron content and spatial distribution of the intracellular iron. Int. J. Mol. Sci. 2013, 14, 9111-9125
141. Gramoun, A.; Crowe, L.A.; Maurizi, L.; Wirth, W.; Tobalem, F.; Grosdemange, K.; Coullerez, G.; Eckstein, F.; Koenders, M.I.; van den Berg, W.B. et al. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res. Ther. 2014, 16, R131
142. Scharlach, C.; Kratz, H.; Wiekhorst, F.; Warmuth, C.; Schnorr, J.; Genter, G.; Ebert, M.; Mueller, S.; Schellenberger, E. Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: Evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining. Nanomed. Nanotechnol. Biol. Med. 2015, 11, 1085-1095
143. Langheinrich, A.C.; Michniewicz, A.; Sedding, D.G.; Lai, B.; Jorgensen, S.M.; Bohle, R.M.; Ritman, E.L. Quantitative X-ray imaging of intraplaque hemorrhage in aortas of apoE−/−/LDL−/− double knockout mice. Investig. Radiol. 2007, 42, 263-273
144. Di Corato, R.; Bigall, N.C.; Ragusa, A.; Dorfs, D.; Genovese, A.; Marotta, R.; Manna, L.; Pellegrino, T. Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: Synthesis and cancer cell targeting and sorting. ACS Nano 2011, 5, 1109-1121
145. Rosca, E.V.; Wright, M.; Gonitel, R.; Gedroyc, W.; Miller, A.D.; Thanou, M. Thermosensitive, near infrared-labelled nanoparticles for topotecan delivery to tumours. Mol. Pharm. 2015, 12, 1335-1346
146. Galbiati, E.; Cassani, M.; Verderio, P.; Martegani, E.; Colombo, M.; Tortora, P.; Mazzucchelli, S.; Prosperi, D. Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates. Bioconjug. Chem. 2015, 26, 680-689
147. Shim, W.; Paik, M.J.; Nguyen, D.-T.; Lee, J.-K.; Lee, Y.; Kim, J.-H.; Shin, E.-H.; Kang, J.S.; Jung, H.-S.; Choi, S. et al. Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. ACS Nano 2012, 6, 7665-7680
148. Han, J.; Kim, B.; Shin, J.-Y.; Ryu, S.; Noh, M.; Woo, J.; Park, J.-S.; Lee, Y.; Lee, N.; Hyeon, T. et al. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells’ therapeutic efficacy for myocardial infarction. ACS Nano 2015, 9, 2805-2819
149. Vanhecke, D.; Rodriguez-Lorenzo, L.; Clift, M.J.; Blank, F.; Petri-Fink, A.; Rothen-Rutishauser, B. Quantification of nanoparticles at the single-cell level: An overview about state-of-the-art techniques and their limitations. Nanomedicine 2014, 9, 1885-1900
150. Graves, E.E.; Ripoll, J.; Weissleder, R.; Ntziachristos, V. A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med. Phys. 2003, 30, 901-911
151. Tan, Y.; Jiang, H. Diffuse optical tomography guided quantitative fluorescence molecular tomography. Appl. Opt. 2008, 47, 2011-2016
152. Tan, Y.; Cao, Z.; Sajja, H.K.; Lipowska, M.; Wang, Y.A.; Yang, L.; Jiang, H. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging. J. X-ray Sci. Technol. 2013, 21, 43-52
153. Liu, W.; Frank, J.A. Detection and quantification of magnetically labeled cells by cellular MRI. Eur. J. Radiol. 2009, 70, 258-264
154. Liu, Y.; Yang, Y.; Zhang, C. A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes. Int. J. Nanomed. 2013, 8, 1083-1093
155. Young, I.R.; Cox, I.J.; Bryant, D.J.; Bydder, G.M. The benefits of increasing spatial resolution as a means of reducing artifacts due to field inhomogeneities. Magn. Reson. Imaging 1988, 6, 585-590
156. Frahm, J.; Merboldt, K.D.; Hanicke, W. Direct FLASH MR imaging of magnetic field inhomogeneities by gradient compensation. Magn. Reson. Med. 1988, 6, 474-480
157. Kuhlpeter, R.; Dahnke, H.; Matuszewski, L.; Persigehl, T.; von Wallbrunn, A.; Allkemper, T.; Heindel, W.L.; Schaeffter, T.; Bremer, C. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: In vitro and murine in vivo testing. Radiology 2007, 245, 449-457
158. Walczak, P.; Kedziorek, D.A.; Gilad, A.A.; Barnett, B.P.; Bulte, J.W. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: The case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 2007, 58, 261-269
159. Gutierrez, L.; Mejias, R.; Barber, D.F.; Veintemillas-Verdaguer, S.; Serna, C.J.; Lazaro, F.J.; Morales, M.P. Ac magnetic susceptibility study of in vivo nanoparticle biodistribution. J. Phys. D Appl. Phys. 2011, 44, 255002
160. Mejías, R.; Gutiérrez, L.; Salas, G.; Pérez-Yagüe, S.; Zotes, T.M.; Lázaro, F.J.; Morales, M.P.; Barber, D.F. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications. J. Control. Release 2013, 171, 225-233
161. Maurizi, L.; Sakulkhu, U.; Gramoun, A.; Vallee, J.-P.; Hofmann, H. A fast and reproducible method to quantify magnetic nanoparticle biodistribution. Analyst 2014, 139, 1184-1191
162. Zysler, R.D.; Lima, E., Jr.; Vasquez Mansilla, M.; Troiani, H.E.; Mojica Pisciotti, M.L.; Gurman, P.; Lamagna, A.; Colombo, L. A new quantitative method to determine the uptake of SPIONs in animal tissue and its application to determine the quantity of nanoparticles in the liver and lung of Balb-c mice exposed to the SPIONs. J. Biomed. Nanotechnol. 2013, 9, 142-145
163. Dobosz, B.; Krzyminiewski, R.; Schroeder, G.; Kurczewska, J. Electron paramagnetic resonance as an effective method for a characterization of functionalized iron oxide. J. Phys. Chem. Solids 2014, 75, 594-598
164. Chertok, B.; Cole, A.J.; David, A.E.; Yang, V.C. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol. Pharm. 2010, 7, 375-385
165. Hoopes, P.J.; Petryk, A.A.; Gimi, B.; Giustini, A.J.; Weaver, J.B.; Bischof, J.; Chamberlain, R.; Garwood, M. In vivo imaging and quantification of iron oxide nanoparticle uptake and biodistribution. Proc. SPIE 2012, doi:10.1117/12.916097
166. Wang, L.; Corum, C.A.; Idiyatullin, D.; Garwood, M.; Zhao, Q. T1 estimation for aqueous iron oxide nanoparticle suspensions using a variable flip angle SWIFT sequence. Magn. Reson. Med. 2013, 70, 341-347
167. Gleich, B.; Weizenecker, J. Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005, 435, 1214-1217
168. Loewa, N.; Wiekhorst, F.; Gemeinhardt, I.; Ebert, M.; Schnorr, J.; Wagner, S.; Taupitz, M.; Trahms, L. Cellular uptake of magnetic nanoparticles quantified by magnetic particle spectroscopy. Magn. IEEE Trans. 2013, 49, 275-278
169. Wang, H.; Kumar, R.; Nagesha, D.; Duclos, R.I., Jr.; Sridhar, S.; Gatley, S.J. Integrity of 111In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nucl. Med. Biol. 2015, 42, 65-70
170. Bargheer, D.; Giemsa, A.; Freund, B.; Heine, M.; Waurisch, C.; Stachowski, G.M.; Hickey, S.G.; Eychmuller, A.; Heeren, J.; Nielsen, P. The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice. Beilstein J. Nanotechnol. 2015, 6, 111-123
171. Cook, J.R.; Frey, W.; Emelianov, S. Quantitative photoacoustic imaging of nanoparticles in cells and tissues. ACS Nano 2013, 7, 1272-1280
172. Freund, B.; Tromsdorf, U.I.; Bruns, O.T.; Heine, M.; Giemsa, A.; Bartelt, A.; Salmen, S.C.; Raabe, N.; Heeren, J.; Ittrich, H. et al. A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano 2012, 6, 7318-7325
173. Yang, X.; Hong, H.; Grailer, J.J.; Rowland, I.J.; Javadi, A.; Hurley, S.A.; Xiao, Y.; Yang, Y.; Zhang, Y.; Nickles, R.J. et al. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 2011, 32, 4151-4160
174. Hoffman, D.; Sun, M.; Yang, L.; McDonagh, P.R.; Corwin, F.; Sundaresan, G.; Wang, L.; Vijayaragavan, V.; Thadigiri, C.; Lamichhane, N. et al. Intrinsically radiolabelled [59Fe]-SPIONs for dual MRI/radionuclide detection. Am. J. Nucl. Med. Mol. Imaging 2014, 4, 548-560
175. Chakravarty, R.; Valdovinos, H.F.; Chen, F.; Lewis, C.M.; Ellison, P.A.; Luo, H.; Meyerand, M.E.; Nickles, R.J.; Cai, W. Intrinsically germanium-69-labeled iron oxide nanoparticles: Synthesis and in vivo dual-modality PET/MR imaging. Adv. Mater. 2014, 26, 5119-5123
176. Bauer, A.Q.; Nothdurft, R.E.; Erpelding, T.N.; Wang, L.V.; Culver, J.P. Quantitative photoacoustic imaging: Correcting for heterogeneous light fluence distributions using diffuse optical tomography. J. Biomed. Opt. 2011, 16, 096016
177. Vetten, M.A.; Yah, C.S.; Singh, T.; Gulumian, M. Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications. Nanomed. Nanotechnol. Biol. Med. 2014, 10, 1391-1399
178. Pirani, P.; Patil, U.; Apsunde, T.; Trudell, M.; Cai, Y.; Tarr, M. Protein surface labeling reactivity of N-hydroxysuccinimide esters conjugated to Fe3O4@SiO2 magnetic nanoparticles. J. Nanopart. Res. 2015, 17, 1-11
179. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823-839
180. Singh, N.; Manshian, B.; Jenkins, G.J.S.; Griffiths, S.M.; Williams, P.M.; Maffeis, T.G.G.; Wright, C.J.; Doak, S.H. NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30, 3891-3914.